Pulmonary Arterial Hypertension in pregnancy causes significant maternal and fetal morbidity. There is currently no consensus on recommendations for overall management in pregnancies complicated by pulmonary arterial hypertension. We recommend institutions help build a multidisciplinary team with knowledge about pulmonary arterial hypertension to coordinate care during pregnancy, at delivery and in the postpartum period. The purpose of this article is to highlight some of the challenges in caring for these women, review the literature and help guide care teams by outlining our management process for 5 pregnant patients with WHO Group 1 pulmonary arterial hypertension on epoprostenol.
Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy